<DOC>
	<DOCNO>NCT02754999</DOCNO>
	<brief_summary>In open-label study , eligible consent adult patient admit hospital critical care acute severe anemia , define blood hemoglobin level ≤ 5 g/dL , unwilling unable receive red blood cell ( RBC ) transfusion , receive one infusion SANGUINATE deem necessary Investigator survival acute anemic episode .</brief_summary>
	<brief_title>A Phase 1 Safety Study SANGUINATE™ In Patients With Acute Severe Anemia .</brief_title>
	<detailed_description>Data collection patient in-patient portion study require maximum 14 day critical care , additional collection safety-related finding 7 day 14 day last infusion SANGUINATE . Each patient thus 28 day participation trial . A minimum 100 subject enrol receive least one infusion SANGUINATE , 14-day follow-up last infusion . Because life-threatening effect severe anemia , expect patient trial receive care within critical care facility ( may call intensive care similar name ) , wherein patient real-time monitoring vital sign ECG ( e.g. , telemetry ) , , study drug infusion .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<criteria>1 . The patient would otherwise receive RBC transfusion treatment severe anemia ( hemolytic/allosensitized compatible blood ) ( religious/personal objection ) receive RBCs 2 . Hemoglobin ≤ 5 g/dL , hemoglobin ≤ 7 g/dL follow decline ≥ 5 g/dL less 7 day 3 . Age ≥ 18 year 4 . Receiving willing receive supplemental iron therapy ( unless contraindicate ) 5 . Receiving willing receive erythropoiesisstimulating agent ( EPO ) therapy 6 . Patient legally authorize representative provide consent participate 7 . Investigator determination patient appropriate candidate study enrollment 1 . Hemoglobin ≤ 2 g/dL 2 . Presence severe trauma ( e.g. , Injury Severity Score ( ISS ) /New Injury Severity Score ( NISS ) Score ≥ 25 ) 3 . Unable provide sufficient blood sample volume screen assessment ; 4 . Pregnant ; 5 . Investigator determination patient appropriate candidate study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>